- Email: [email protected]
Idex to acquire Scivex
May 2004
Pump Industry Analyst
NEWS
IDEX TO ACQUIRE SCIVEX Idex Corp has entered into a definitive agreement to acquire Scivex Inc, a provider of fluidic components and systems for the analytical, biotechnology and diagnostic instrumentation markets. With annual sales of US$31 million, Scivex operates Upchurch Scientific in Oak Harbor, Washington, Sapphire Engineering in Pocasset, Massachusetts, and JL White in Santa Clara, California. Its primary products include a wide variety of high tech components including fittings, tubing, check valves, pistons, filters as well as dispensing pumps, micro and nano-scale fluidic modules. Idex plans to operate Scivex as a standalone business in its Pump Products Group. Scivex is a portfolio company of KRG Capital Partners, a middle market private equity firm based in Denver, Colorado. • Idex has also acquired Systec Inc, a manufacturer of vacuum degassing products for the analytical chemistry instrumentation market. Systec will also be operated as part of Idex’s Pump Products Group. Headquartered in New Brighton, Minnesota, Systec has annual sales of approximately US$9 million. Its primary products include miniaturized Teflon diaphragm vacuum pumps and controls, Teflon AF degassing chambers and transfer lines and spectrophotometer flow cells.
STRONG START TO 2004 FOR SULZER PUMPS Switzerland’s Sulzer Pumps has increased first quarter order intake by 15% to SFr276 million.
16
This is Sulzer Pumps’ highest order volume since the first quarter of 2002. All Sulzer Pumps’ segments increased order intake with sustained good markets in Asia and Europe. Both the oil and gas segment and the pulp and paper segment developed strongly during the quarter. As a group Sulzer Ltd had a fairly weak fourth quarter in 2003, but has experienced a strong start to 2004. Overall orders increased 14% to SFr548 million. Sulzer expects orders to develop positively over the coming months. The company anticipates that Asian markets will remain lively, while the North American and European markets should continue to improve.
FLOWSERVE PLANS BRAND RE-LAUNCH With a growing share of its business coming from outside the United States, Flowserve’s branding strategy is going global. The company has selected Birmingham, UK-headquartered Wyatt International as its agency of record to lead the company’s brand re-launch. Wyatt will lead the strategy to distinguish Flowserve as a “branded house” that leverages the heritage product lines that the company has acquired over the past seven years. “Flowserve is building its marketing strategy to be aligned with supporting our customers’ efforts to achieve their financial and operational objectives,” said John Jacko, Flowserve’s vice president of marketing and communications. “Our branding strategy must communicate and reinforce Flowserve’s strengths and capabilities around the world as well as our local availability near customer operations.” Jacko added that Wyatt would help to further develop the company’s
core brand strategy, and then implement that strategy through a launch of new branding elements in the second half of 2004. Wyatt will also simultaneously lead the consolidation of the advertising and marketing communication agency fees spent across the company.
SKF TO BUY WILLY VOGEL Bearing giant SKF has signed a memorandum of understanding to acquire Willy Vogel AG and its subsidiaries. Vogel specializes in centralized lubrication technology for machinery and systems as well as commercial and rail vehicles. The company’s Spandau Pumps division manufactures liquid pumps for a number of industrial and process-engineering applications. In addition to the German plants in Berlin and Hockenheim, Willy Vogel has further production facilities in Japan and the USA. 2004 sees Vogel celebrate its 75th year in business. As part of SKF, Vogel says that it will be able to get closer to worldwide customers, reach new segments and markets and open opportunities for customers, partners, distributors and suppliers. “We will provide SKF the best knowledge, engineering and customization of lubrication systems that exists in the industry,” says Manfred Neubert, CEO of Vogel. “This acquisition gives SKF the critical mass in lubrication systems and we can create a centre of excellence for lubrication activities within the Group,” says Tom Johnstone, SKF CEO. “It gives us a great opportunity to increase customer value by offering complementary products, services and solutions.” Vogel will be part of the SKF’s Industrial Division and operate as a separate business unit.
Editor Roisin Reidy Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.worldpumps.com Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions @elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.nl), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02167 Printed by Mayfield Press (Oxford) Limited, UK.
Pump Industry Analyst
NEWS
IDEX TO ACQUIRE SCIVEX Idex Corp has entered into a definitive agreement to acquire Scivex Inc, a provider of fluidic components and systems for the analytical, biotechnology and diagnostic instrumentation markets. With annual sales of US$31 million, Scivex operates Upchurch Scientific in Oak Harbor, Washington, Sapphire Engineering in Pocasset, Massachusetts, and JL White in Santa Clara, California. Its primary products include a wide variety of high tech components including fittings, tubing, check valves, pistons, filters as well as dispensing pumps, micro and nano-scale fluidic modules. Idex plans to operate Scivex as a standalone business in its Pump Products Group. Scivex is a portfolio company of KRG Capital Partners, a middle market private equity firm based in Denver, Colorado. • Idex has also acquired Systec Inc, a manufacturer of vacuum degassing products for the analytical chemistry instrumentation market. Systec will also be operated as part of Idex’s Pump Products Group. Headquartered in New Brighton, Minnesota, Systec has annual sales of approximately US$9 million. Its primary products include miniaturized Teflon diaphragm vacuum pumps and controls, Teflon AF degassing chambers and transfer lines and spectrophotometer flow cells.
STRONG START TO 2004 FOR SULZER PUMPS Switzerland’s Sulzer Pumps has increased first quarter order intake by 15% to SFr276 million.
16
This is Sulzer Pumps’ highest order volume since the first quarter of 2002. All Sulzer Pumps’ segments increased order intake with sustained good markets in Asia and Europe. Both the oil and gas segment and the pulp and paper segment developed strongly during the quarter. As a group Sulzer Ltd had a fairly weak fourth quarter in 2003, but has experienced a strong start to 2004. Overall orders increased 14% to SFr548 million. Sulzer expects orders to develop positively over the coming months. The company anticipates that Asian markets will remain lively, while the North American and European markets should continue to improve.
FLOWSERVE PLANS BRAND RE-LAUNCH With a growing share of its business coming from outside the United States, Flowserve’s branding strategy is going global. The company has selected Birmingham, UK-headquartered Wyatt International as its agency of record to lead the company’s brand re-launch. Wyatt will lead the strategy to distinguish Flowserve as a “branded house” that leverages the heritage product lines that the company has acquired over the past seven years. “Flowserve is building its marketing strategy to be aligned with supporting our customers’ efforts to achieve their financial and operational objectives,” said John Jacko, Flowserve’s vice president of marketing and communications. “Our branding strategy must communicate and reinforce Flowserve’s strengths and capabilities around the world as well as our local availability near customer operations.” Jacko added that Wyatt would help to further develop the company’s
core brand strategy, and then implement that strategy through a launch of new branding elements in the second half of 2004. Wyatt will also simultaneously lead the consolidation of the advertising and marketing communication agency fees spent across the company.
SKF TO BUY WILLY VOGEL Bearing giant SKF has signed a memorandum of understanding to acquire Willy Vogel AG and its subsidiaries. Vogel specializes in centralized lubrication technology for machinery and systems as well as commercial and rail vehicles. The company’s Spandau Pumps division manufactures liquid pumps for a number of industrial and process-engineering applications. In addition to the German plants in Berlin and Hockenheim, Willy Vogel has further production facilities in Japan and the USA. 2004 sees Vogel celebrate its 75th year in business. As part of SKF, Vogel says that it will be able to get closer to worldwide customers, reach new segments and markets and open opportunities for customers, partners, distributors and suppliers. “We will provide SKF the best knowledge, engineering and customization of lubrication systems that exists in the industry,” says Manfred Neubert, CEO of Vogel. “This acquisition gives SKF the critical mass in lubrication systems and we can create a centre of excellence for lubrication activities within the Group,” says Tom Johnstone, SKF CEO. “It gives us a great opportunity to increase customer value by offering complementary products, services and solutions.” Vogel will be part of the SKF’s Industrial Division and operate as a separate business unit.
Editor Roisin Reidy Elsevier Advanced Technology PO Box 150 Kidlington Oxford OX5 1AS United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.worldpumps.com Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions @elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.nl), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02167 Printed by Mayfield Press (Oxford) Limited, UK.